Beyond Air (XAIR) Competitors $0.20 +0.00 (+1.68%) Closing price 03:58 PM EasternExtended Trading$0.21 +0.01 (+7.00%) As of 04:16 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock XAIR vs. APYX, ZYXI, SURG, ICCM, TELA, APT, CTSO, SPAI, MODD, and PTHLShould you be buying Beyond Air stock or one of its competitors? The main competitors of Beyond Air include Apyx Medical (APYX), Zynex (ZYXI), SurgePays (SURG), IceCure Medical (ICCM), TELA Bio (TELA), Alpha Pro Tech (APT), Cytosorbents (CTSO), Safe Pro Group Inc. Common Stock (SPAI), Modular Medical (MODD), and Pheton Holdings Ltd Class A Ordinary Shares (PTHL). These companies are all part of the "medical equipment" industry. Beyond Air vs. Apyx Medical Zynex SurgePays IceCure Medical TELA Bio Alpha Pro Tech Cytosorbents Safe Pro Group Inc. Common Stock Modular Medical Pheton Holdings Ltd Class A Ordinary Shares Apyx Medical (NASDAQ:APYX) and Beyond Air (NASDAQ:XAIR) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their earnings, community ranking, risk, valuation, profitability, dividends, analyst recommendations, media sentiment and institutional ownership. Do analysts rate APYX or XAIR? Beyond Air has a consensus target price of $1.50, indicating a potential upside of 650.00%. Given Beyond Air's stronger consensus rating and higher possible upside, analysts clearly believe Beyond Air is more favorable than Apyx Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Apyx Medical 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.67Beyond Air 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.00 Do institutionals & insiders have more ownership in APYX or XAIR? 55.3% of Apyx Medical shares are held by institutional investors. Comparatively, 31.5% of Beyond Air shares are held by institutional investors. 16.8% of Apyx Medical shares are held by insiders. Comparatively, 19.4% of Beyond Air shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Is APYX or XAIR more profitable? Apyx Medical has a net margin of -58.59% compared to Beyond Air's net margin of -1,730.00%. Apyx Medical's return on equity of -137.98% beat Beyond Air's return on equity.Company Net Margins Return on Equity Return on Assets Apyx Medical-58.59% -137.98% -36.74% Beyond Air -1,730.00%-226.01%-109.75% Does the MarketBeat Community believe in APYX or XAIR? Apyx Medical received 30 more outperform votes than Beyond Air when rated by MarketBeat users. However, 69.57% of users gave Beyond Air an outperform vote while only 60.94% of users gave Apyx Medical an outperform vote. CompanyUnderperformOutperformApyx MedicalOutperform Votes7860.94% Underperform Votes5039.06% Beyond AirOutperform Votes4869.57% Underperform Votes2130.43% Does the media prefer APYX or XAIR? In the previous week, Apyx Medical and Apyx Medical both had 2 articles in the media. Apyx Medical's average media sentiment score of 1.89 beat Beyond Air's score of 0.94 indicating that Apyx Medical is being referred to more favorably in the media. Company Overall Sentiment Apyx Medical Very Positive Beyond Air Positive Which has preferable valuation and earnings, APYX or XAIR? Apyx Medical has higher revenue and earnings than Beyond Air. Apyx Medical is trading at a lower price-to-earnings ratio than Beyond Air, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioApyx Medical$47.29M1.43-$18.71M-$0.55-3.26Beyond Air$3.02M5.71-$60.24M-$1.06-0.19 Which has more volatility and risk, APYX or XAIR? Apyx Medical has a beta of 1.21, meaning that its share price is 21% more volatile than the S&P 500. Comparatively, Beyond Air has a beta of 0.23, meaning that its share price is 77% less volatile than the S&P 500. SummaryApyx Medical beats Beyond Air on 10 of the 17 factors compared between the two stocks. Get Beyond Air News Delivered to You Automatically Sign up to receive the latest news and ratings for XAIR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart XAIR vs. The Competition Export to ExcelMetricBeyond AirSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$16.99M$4.38B$5.57B$8.67BDividend YieldN/A42.67%5.27%4.19%P/E Ratio-0.1928.2027.2120.17Price / Sales5.6270.64414.99161.94Price / CashN/A51.0838.2534.64Price / Book0.735.967.124.72Net Income-$60.24M$67.01M$3.23B$247.80M7 Day Performance4.63%1.53%3.80%2.76%1 Month Performance0.31%18.46%13.40%9.71%1 Year Performance-84.51%19.19%32.04%14.51% Beyond Air Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)XAIRBeyond Air4.3565 of 5 stars$0.20+1.7%$1.50+650.0%-84.0%$17.27M$3.02M-0.1970News CoverageUpcoming EarningsGap UpHigh Trading VolumeAPYXApyx Medical1.9591 of 5 stars$1.62+3.8%N/A+13.8%$61.23M$47.29M-1.95270ZYXIZynex2.9764 of 5 stars$2.02-13.7%$6.00+197.0%-76.9%$61.08M$172.40M13.47770High Trading VolumeSURGSurgePays3.3383 of 5 stars$2.97+8.0%$8.75+194.6%-32.0%$60.62M$40.03M-2.6340ICCMIceCure Medical2.7104 of 5 stars$1.05flat$2.50+138.1%+36.2%$58.28M$3.27M-3.6260Gap DownTELATELA Bio2.3815 of 5 stars$1.42+2.2%$7.25+410.6%-65.5%$56.17M$71.22M-0.84120Positive NewsAPTAlpha Pro Tech1.1587 of 5 stars$5.01+6.1%N/A-7.5%$54.43M$58.18M13.54120High Trading VolumeCTSOCytosorbents1.8789 of 5 stars$0.86+2.1%$5.50+541.0%+19.1%$53.72M$35.33M-2.38220Gap UpSPAISafe Pro Group Inc. Common StockN/A$2.90+10.7%N/AN/A$44.00M$2.05M-3.5811News CoveragePositive NewsGap UpMODDModular Medical2.1365 of 5 stars$0.79-8.2%N/A-50.2%$42.85MN/A-1.4920Positive NewsPTHLPheton Holdings Ltd Class A Ordinary SharesN/A$6.29+1.5%N/AN/A$41.40M$448,196.000.0011High Trading Volume Related Companies and Tools Related Companies Apyx Medical Competitors Zynex Competitors SurgePays Competitors IceCure Medical Competitors TELA Bio Competitors Alpha Pro Tech Competitors Cytosorbents Competitors Safe Pro Group Inc. Common Stock Competitors Modular Medical Competitors Pheton Holdings Ltd Class A Ordinary Shares Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:XAIR) was last updated on 6/11/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Beyond Air, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Beyond Air With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
